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Background:  Proteins HMG1 and HMG2 are two of the most abundant non histone proteins in
the nucleus of mammalian cells, and contain a domain of homology with many proteins implicated
in the control of development, such as the sex-determination factor Sry and the Sox family of pro-
teins. In vitro studies of interactions of HMG1/2 with DNA have shown that these proteins can
bind to many unusual DNA structures, in particular to four-way junctions, with binding affinities of
107 to 109 M-1.
Results:  Here we show that HMG1 and HMG2 bind with a much higher affinity, at least 4 orders
of magnitude higher, to a new structure, Form X, which consists of a DNA loop closed at its base
by a semicatenated DNA junction, forming a DNA hemicatenane. The binding constant of HMG1
to Form X is higher than 5 × 1012 M-1, and the half-life of the complex is longer than one hour in
vitro.
Conclusions:  Of all DNA structures described so far with which HMG1 and HMG2 interact, we
have found that Form X, a DNA loop with a semicatenated DNA junction at its base, is the struc-
ture with the highest affinity by more than 4 orders of magnitude. This suggests that, if similar struc-
tures exist in the cell nucleus, one of the functions of these proteins might be linked to the
remarkable property of DNA hemicatenanes to associate two distant regions of the genome in a
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Interaction of proteins HMG1 and HMG2 with Form X. (A) It 
was previously observed that a double-stranded 120 bp DNA 
fragment containing a 60 bp tract of the repetitive sequence 
poly(CA)¡ poly(TG), when end-labelled and used in a gel re-
tardation experiment with a nuclear extract of cultured mon-
key cells (CV1 line) in the presence of high amounts of E. coli 
competitor DNA, could give rise to two retarded bands, C1 
and C2, corresponding to specific DNA-protein complexes 
[33]. (B) The proteins responsible for the formation of retard-
ed bands C1 and C2 were purified and identified as proteins 
HMG1 and HMG2 [33]. (C) The DNA contained in retarded 
bands C1 and C2 was purified: on a polyacrylamide gel it mi-
grated more slowly than the regular double-stranded frag-
ment and showed a series of bands, initially named "Form X", 
which reformed complexes C1 and C2 by interaction with 
HMG1/2, and which have been identified [34] as DNA loops 
maintained at their base by a semicatenated DNA junction. A 
highly schematic representation of the structure of Form X is 
shown, showing the junction in which two DNA duplexes 
cross with one of the strands of one duplex passing between 
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Comparison of the interactions of HMG1 with Form X and 
cruciform. The concentrations used were: Form X: 3.5 × 10-
11 M ; cruciform: 1.5 × 10-10 M ; undiluted HMG1: 3.2 × 10-8 
M. (A) Form X (left) and cruciform (right) were labelled and 
incubated with a constant amount of HMG1 in the presence 
of increasing amounts of unlabelled E. coli competitor DNA. 
Lanes C are controls with no protein added. It is observed 
that Form X is entirely bound by HMG1 at all the competitor 
concentrations used. In contrast, cruciform is only partially 
bound in the first sample, and the amount of complex de-
creases quickly when the amount of competitor DNA is in-
creased. Also note that linear DNA in its regular double-
stranded form is not bound at all. (B) labelled Form X and cru-
ciform were incubated in the presence of decreasing amounts 
of protein HMG1, with no addition of competitor DNA. 
Lanes C contain controls with no protein added. The protein 
amounts are 10, 2, 0.4, 0.08, and 0.016 ng in lanes 1 to 5, re-
spectively. Both central samples contain a mixture of Form X 
plus cruciform. To better compare the results with data pub-
lished in the literature, the interactions and electrophoreses 
of the experiments shown in this Figure were strictly done un-
der the conditions used in [26], 6.5% polyacrylamide gels in 
Tris-borate buffer, resulting in a change in mobility of Form X 
and of Form X-HMG1/2 complex as compared to experi-
ments of Figures 1, 3 and 4, which were done in 4% polyacr-
ylamide gels in Tris-acetate buffer. All the experiments shown 
here were also performed with HMG2, with identical results.
Figure 3
Interactions of Form X with variable concentrations of 
HMG1. Form X, end-labelled to the highest possible specific 
activity, was incubated with serial dilutions of protein HMG1. 
(A) The interactions were performed at three different con-
centrations of Form X (16 pM, 1.6 pM, and 0.16 pM). For each 
concentration the quantification of the radioactivity in the 
bands was performed with a phosphorimager, allowing us to 
determine the HMG1 concentration necessary to bind 50% of 
the Form X. (B) The results were plotted on a double loga-
rithmic scale, showing that the protein concentration at half 
saturation (expressed as a dilution factor of a protein stock at 
~ 20 µg/mL i.e. ~ 8 × 10-7 M) decreases with the concentra-
tion of Form X in the samples, and therefore that the K D of 
the interaction is lower than 0.16 pM.
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Stability of the complex between HMG1 and Form X as a 
function of time.(A) Complexes between labelled Form X and 
HMG1 were first formed during a 30 min incubation at 37° 
(lane 0, concentration of Form X = 10-11 M; concentration ra-
tio [HMG1]/[FormX] ≅ 2). At time 0, a 40 fold excess of un-
labelled Form X was added and incubation at 37° was 
resumed. At each indicated time, from 1 min to 120 min, a 
sample was taken from the incubation mixture and immedi-
ately loaded on a running polyacrylamide gel, thus freezing the 
dissociation process. The curved shape of the autoradiogram 
is due to the fact that the first samples have migrated 4 hr 
while the last loaded samples have migrated 2 hr only. Con-
trols: C, Form X with no protein added; ∞, competitor was 
added before the protein, which mimics complete protein re-
distribution after an incubation for an infinite time. (B) The ra-
dioactivity in the bands in (A) was counted with a 
phosphorimager and plotted as a function of time. Squares 
and green line: complex C2; triangles and blue line: complex 
C1; circles and red line: free Form X. (C) Best fit obtained by 
simulating the experiment with the program Chemical Kinet-
ics Simulator, yielding estimates of for the dissociation time 
constants koff equal to 1.7 × 10-4 s-1 for complex C1 and 1.2 
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